Clearday (CLRD) Stock Price

Clearday Price

OTC·CLOSED
0.00
​
Market closed

Revenue at Clearday has contracted by 7.0% per year over the past 19 years to 12.49 M USD. For Clearday, the net margin of -167.6% is up versus -522.6% a few years ago.

Clearday stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Clearday business model & stock analysis

Clearday, Inc. generates revenue through its longevity-tech platform, which connects families with senior care communities to address operational and care gaps in the aging population market. The platform offers features like live events, group calls, and management of OT/PT services to enhance monitoring and engagement for older Americans with dementia or cognitive issues. Clearday Labs develops digital and robotic services within this platform, supporting the ability of older Americans to age in place. The primary buyers are families of seniors requiring care in memory and Alzheimer's treatment venues, as well as care communities managing treatment adherence and therapy engagement. The company’s products are designed for senior care venues specializing in memory and Alzheimer's care, where families seek solutions for monitoring and engagement. Clearday Labs focuses on creating digital and robotic services that integrate with the platform to provide new insights and support for aging in place. These services target older Americans facing physical and cognitive challenges, with the platform enabling dedicated connections between families and care providers. Clearday Inc. serves segments including families of seniors with dementia and care communities managing treatment adherence. The platform’s features, such as live events and therapy management, cater to the needs of older Americans requiring support for lifestyle-limiting physical and cognitive issues. The company’s revenue model is built on delivering these care solutions through its purpose-built longevity-tech platform, which is tailored to the specific challenges of senior care venues.

Frequently asked questions about Clearday

7 analysts currently rate the Clearday stock: 6 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Clearday share trades at 0.00 EUR (0.00 USD).

The Clearday share (CLRD) is listed on 2 stock exchanges, including: London (0ZB6.L).

The revenue cannot currently be calculated for Clearday.

The profit cannot currently be calculated for Clearday.

The P/E ratio cannot be calculated for Clearday at the moment.

The P/S cannot be calculated for Clearday currently.

The Eulerpool Quality Score for Clearday is 7/10.

The ISIN of Clearday is US1847911013. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Clearday is CLRD. The ticker symbol is used to trade Clearday shares on the stock exchange.

Fair ValueTerminal
0.00 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue per Employee
55,511.11 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Mar 9, 1993
ISIN
US1847911013
Cusip
184791101
Market capitalization
1,751.00 USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.00
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
84.77 %
Last updated Nov 10, 2026, 3:51 AM

Clearday Peer Group

Clearday Ticker

LONDON · 0ZB6.LOTC · CLRD

Clearday FIGI

CLRD:US · BBG000BH12X7CLRD:PQ · BBG000BH1BF7CLRD:UV · BBG000BH1CB90ZB6:LN · BBG00LN7HX83

All fundamentals and in-depth analysis of Clearday

Our stock analysis for Clearday stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Clearday. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.